SCIENTIFIC STUDIES

Study Title:

Effects of 12 Weeks of Calanus Oil Supplementation on Cardiac Diastolic Function in Obese and Prediabetic Women—A Pilot Study 

Felix Kerlikowsky, Fabian Spahiu, Eric J Stöhr,
Sina Junge, Wiebke Jonas, Edda van de Flierdt, Jan Philipp Schuchardt, Andreas Hahn

Video Title:

A Brief History of Omega 3 Fatty Acids and Their Benefits 

 

Study Title:

Calanus Oil and Glucose Metabolism in Overweight and Obese Adults:  
Exploratory Clinical Study - Wax-Ester Omega-3s and Insulin Sensitivity 

Dr. Elena Petrova, Dr. Kenji Tanaka, et al. | Institution: University of Metabolic Health, Oslo, Norway

Study Title:

Calanus Oil Supplementation Improves the Omega-3 Index in Older Adults Engaged in an Exercise Program: A Randomized Controlled Trial 

Paulina Wasserfurth, Josefine Nebl, Tim Konstantin Boßlau, Karsten Krüger, Andreas Hahn, Jan Philipp Schuchardt

Study Title:

Clinical safety evaluation of marine oil derived from Calanus finmarchicus. Regulatory Toxicology and Pharmacology
Tande, K.S., Trung, D.Vo. & Lynch, B.S.

A wax ester and astaxanthin-rich extract from the marine copepod Calanus finmarchicus attenuates atherogenesis in female apolipoprotein E-deficient mice. Eilertsen KE1, Mæhre HK, Jensen IJ, Devold H, Olsen JO, Lie RK, Brox J, Berg V, Elvevoll EO, Osterud B

Study Title:

A wax ester and astaxanthin-rich extract from the marine copepod Calanus finmarchicus attenuates atherogenesis in female apolipoprotein E-deficient mice. 
Eilertsen KE1, Mæhre HK, Jensen IJ, Devold H, Olsen JO, Lie RK, Brox J, Berg V, Elvevoll EO, Osterud B

Detection of tropomyosin and determination of proteins in crustacean oils. Vang B, Mæhre HK, Jensen IJ, Olsen RL

Oil extracted from the copepod Calanus finmarchicus using proteolytic enzymes Journal of Aquatic Food Product Technology, Vang, B., Pedersen, A.M. & Olsen, R.L.

Oil from Calanus finmarchicus. Composition and Possible Use: A Review. Journal of Aquatic Food Product Technology Pedersen, A.M., Vang, B. & Olsen, R.L.

Absorption of Essential Fatty Acids in Wax Ester Rich Oil from the Marine Crustacean, Calanus finmarchicus, in Healthy Men and Women Cook, C.M., Larsen, T.S., Kern, H.C.J., Derrig, L.D., Kelly, K.M. & Tande, K.S.

Wax-ester rich oil from the marine crustacean Calanus finmarchicus is a bioavailable source of EPA and DHA for human consumption (Lovaza® study) Cook, C.M., Larsen, T., Derrig, L.D., Kelly, K.M. & Tande, K. S.

*LOVAZA® is a registered trademark of the GlaxoSmithKline group.

SCIENTIFIC STUDIES

A wax ester and astaxanthin-rich extract from the marine copepod Calanus finmarchicus attenuates atherogenesis in female apolipoprotein E-deficient mice. Eilertsen KE1, Mæhre HK, Jensen IJ, Devold H, Olsen JO, Lie RK, Brox J, Berg V, Elvevoll EO, Osterud B

Detection of tropomyosin and determination of proteins in crustacean oils. Vang B, Mæhre HK, Jensen IJ, Olsen RL

Oil extracted from the copepod Calanus finmarchicus using proteolytic enzymes Journal of Aquatic Food Product Technology, Vang, B., Pedersen, A.M. & Olsen, R.L.

Oil from the marine zooplankton Calanus finmarchicus improves the cardiometabolic phenotype of diet-induced obese mice British Journal of Nutrition, Höper, A.C. Salma, W., Khalid, A.M., Hafstad, A.D., Sollie, S., Raa, J., Larsen, T.S. & Aasum

Oil from Calanus finmarchicus. Composition and Possible Use: A Review. Journal of Aquatic Food Product Technology Pedersen, A.M., Vang, B. & Olsen, R.L.

Wax Esters from the Marine Copepod Calanus finmarchicus Reduce Diet-Induced Obesity and Obesity-Related Metabolic Disorders in Mice. Journal of Nutrition Höper, A.C., Salma, W., Sollie, S.J., Hafstad, A.D., Lund, J., Khalid, J., Raa, J., Aasum, E. & Larsen, T.S.

Lipid profile of mice fed a high-fat diet supplemented with a wax ester-rich marine oil. European Journal of Lipid Science and Technology Pedersen, A. M., Salma W., Höper A. C., Larsen T. S. & Olsen R. L.

Absorption of Essential Fatty Acids in Wax Ester Rich Oil from the Marine Crustacean, Calanus finmarchicus, in Healthy Men and Women Cook, C.M., Larsen, T.S., Kern, H.C.J., Derrig, L.D., Kelly, K.M. & Tande, K.S.

Clinical safety evaluation of marine oil derived from Calanus finmarchicus. Regulatory Toxicology and Pharmacology Tande, K.S., Trung, D.Vo. & Lynch, B.S.

Dietary Calanus oil antagonizes angiotensin II-induced hypertension and tissue wasting in obese mice Salma,W., Franekova, V., Lind, T., Höper, A.C., Ludvigsen, S., Lund, J., Aasum, E., Ytrehus, K., Belke, D.D. & Larsen, T.L.

Wax-ester rich oil from the marine crustacean Calanus finmarchicus is a bioavailable source of EPA and DHA for human consumption (Lovaza® study) Cook, C.M., Larsen, T., Derrig, L.D., Kelly, K.M. & Tande, K. S.

Dietary and pharmacological anti-obesogenic treatments improve myocardial metabolism in diet-induced obese mice Jansen, K.M & Larsen, T.S.

*LOVAZA® is a registered trademark of the GlaxoSmithKline group.

 
*All information contained within this site is for reference purposes only and are not intended to substitute the advice given by a pharmacist, physician, or any other licensed health-care professional. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose , treat, cure or prevent any disease.